Zhongtai Securities gives Meiya Optoelectronics a buy rating: the company attaches great importance to the development of the medical industry from a strategic perspective, and its operating performance will steadily improve in 2021_Oriental Fortune Network

　　Zhongtai SecuritiesOn March 30, the company issued the title “The company attaches great importance to the development of the medical industry from a strategic perspective, and will operate in 2021.performancesteadily increasing”Research reportsay, giveMeiya Optoelectronics(002690.SZ, latest price: 27.18 yuan) Buy rating.The reasons for the rating mainly include: 1) The performance in 2021 will maintain a steady growth trend, and the profitability will be dragged down by the increase in bulk & shipping prices and foreign exchange losses; 2) Analysis of operating capacity and operating cash flow; 3) Continue to expand research and development, and insist on high-quality product innovation; 4) Stick to positive cashDividend5) The company attaches great importance to the development of the medical industry from a strategic perspective, and the sales of oral CBCT have achieved rapid growth; 6) The company continues to expand the high-end medical imaging product line based on the core technology of photoelectric identification; 7) The company gives full play to The comprehensive competitiveness of products, marketing service system and brand advantages have achieved rapid growth in oral CBCT sales; 8) The company has established a dedicated public hospital sales team, and the market expansion of public hospitals has made positive progress; 9) The company actively expands the global market; 10) Domestic The performance of color sorters was outstanding, and overseas demand for color sorters was dragged down by the increase in shipping prices; 11) The company continued to innovate products and established a wide-coverage and differentiated product system; 12) Under the background of food security, the demand for food processing was rigid, and color Demand for machine selection is stable; 13) Maintain “Buy” rating. Risk warning: The prevention and control of the new crown epidemic is less than expected; the development of the food testing industry is less than expected; the development of overseas business is less than expected; the development of the domestic oral CBCT industry is less than expected; the risk of intensified competition in the domestic oral CBCT market; the development of the chairside repair system is less than expected; foreign exchange gains and losses Uncertain impact on company performance; Uncertain impact of other operating income on company performance.

AI comments:Meiya Optoelectronics2 copies in the past monthbrokerageThe research report is concerned, and 2 are bought.

(Article source: Daily Economic News)

Article source: Daily Economic News

Responsible editor: 6

Original title: Zhongtai Securities gave Meiya Optoelectronics a buy rating: the company attaches great importance to the development of the medical industry from a strategic perspective, and its operating performance will steadily improve in 2021